Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq
Regencell Bioscience shares plunged 18.5% to $43.10 Thursday after hitting $69.97 earlier in the session, triggering five volatility halts. Over 3 million shares traded by early afternoon, far above average. The company has warned of “substantial doubt” about its ability to continue operating and reported net losses of $3.58 million for the year ended June 2025. No company statement explained the sharp swings.